Research Article
The Value of Preoperative Alpha-L-Fucosidase Levels in Evaluation of Malignancy and Differential Diagnosis of Urothelial Neoplasms
Table 1
Correlations between preoperative AFU levels and clinicopathological parameters.
| Variables | No. of patients (%) | AFU levels (U/L, mean ± SD) | value |
| Patients | 599 | 14.94 ± 4.53 | |
| Agea | ≤65y | 306 | 15.30 ± 4.62 | 0.100 | >65y | 293 | 14.57 ± 4.40 |
| Sex | Male | 455 | 15.24 ± 4.61 | 0.001 | Female | 144 | 13.99 ± 4.11 |
| Smoking history | Ever | 220 | 15.42 ± 4.85 | 0.049 | Never | 379 | 14.66 ± 4.30 |
| Painless macroscopic hematuria | Yes | 429 | 15.18 ± 4.34 | 0.010 | No | 170 | 14.34 ± 4.92 |
| Tumor number | Single | 405 | 14.81 ± 4.59 | 0.372 | Multiple | 194 | 15.23 ± 4.38 |
| Tumor sizeab | ≤2.8 cm | 308 | 15.11 ± 4.75 | 0.229 | >2.8 cm | 291 | 14.77 ± 4.28 |
| WBCa | ≤6.25 × 109/L | 301 | 14.54 ± 4.63 | 0.005 | >6.25 × 109/L | 298 | 15.35 ± 4.38 | |
| PLTa | ≤226 × 109/L | 305 | 14.68 ± 4.76 | 0.100 | >226 × 109/L | 294 | 15.22 ± 4.26 |
| AKPa | ≤68 U/L | 316 | 14.73 ± 4.61 | 0.115 | >68 U/L | 283 | 15.19 ± 4.42 |
| LDHa | ≤188 U/L | 305 | 14.57 ± 4.42 | 0.021 | >188 U/L | 294 | 15.33 ± 4.61 |
| PFLa | ≤3.12 g/L | 302 | 15.22 ± 4.68 | 0.115 | >3.12 g/L | 297 | 14.66 ± 4.36 |
| Pathological characteristics | Papilloma | 8 | 14.56 ± 5.22 | 0.803 | PUNLMP | 56 | 14.93 ± 4.67 | Pure UC | 515 | 14.99 ± 4.50 |
| Grade of pure UC | High-grade | 340 | 14.64 ± 4.10 | 0.051 | Low-grade | 175 | 15.67 ± 5.12 |
| Tumor invasion of MUT | Invasive | 328 | 14.79 ± 4.27 | 0.164 | Noninvasive | 118 | 15.38 ± 4.36 | Unknown | 89 | — |
|
|
Continuous variables are expressed as median a. Bold values are statistically significant ( ).PUNLMP papillary urothelial neoplasm of low malignant potential; UC: urothelial cancer; MUT: malignant uroepithelial tumor; WBC: white blood cell; PLT platelet; AKP: alkaline phosphatase; LDH: lactate dehydrogenase; PFL: plasma fibrinogen. : Kruskal–Wallis H-test; : Mann–Whitney U test. |